Interaction Between Domperidone and Ketoconazole: Toward Prediction of Consequent QTc Prolongation Using Purely In Vitro Information
Open Access
- 13 August 2014
- journal article
- Published by Wiley in CPT: Pharmacometrics & Systems Pharmacology
- Vol. 3 (8) , 1-11
Abstract
We aimed to investigate the application of combined mechanistic pharmacokinetic (PK) and pharmacodynamic (PD) modeling and simulation in predicting the domperidone (DOM) triggered pseudo‐electrocardiogram modification in the presence of a CYP3A inhibitor, ketoconazole (KETO), using in vitro–in vivo extrapolation. In vitro metabolic and inhibitory data were incorporated into physiologically based pharmacokinetic (PBPK) models within Simcyp to simulate time course of plasma DOM and KETO concentrations when administered alone or in combination with KETO (DOM+KETO). Simulated DOM concentrations in plasma were used to predict changes in gender‐specific QTcF (Fridericia correction) intervals within the Cardiac Safety Simulator platform taking into consideration DOM, KETO, and DOM+KETO triggered inhibition of multiple ionic currents in population. Combination of in vitro–in vivo extrapolation, PBPK, and systems pharmacology of electric currents in the heart was able to predict the direction and magnitude of PK and PD changes under coadministration of the two drugs although some disparities were detected.CPT Pharmacometrics Syst. Pharmacol. (2014) 3, e130; doi:10.1038/psp.2014.26; published online 13 August 2014Keywords
This publication has 44 references indexed in Scilit:
- Circadian Models of Serum Potassium, Sodium, and Calcium Concentrations in Healthy Individuals and Their Application to Cardiac Electrophysiology Simulations at Individual LevelComputational and Mathematical Methods in Medicine, 2013
- Age and gender dependent heart rate circadian model development and performance verification on the proarrhythmic drug case studyTheoretical Biology and Medical Modelling, 2013
- Computational assessment of drug‐induced effects on the electrocardiogram: from ion channel to body surface potentialsBritish Journal of Pharmacology, 2012
- Inter-individual Variability in the Pre-clinical Drug Cardiotoxic Safety Assessment—Analysis of the Age–Cardiomyocytes Electric Capacitance DependenceJournal of Cardiovascular Translational Research, 2012
- Pharmacokinetic interaction between domperidone and ketoconazole leads to QT prolongation in healthy volunteers: a randomized, placebo‐controlled, double‐blind, crossover studyBritish Journal of Clinical Pharmacology, 2012
- Acquired Long QT Interval: A Case Series of Multifactorial QT ProlongationClinical Cardiology, 2011
- A Novel Domperidone Hydrogel: Preparation, Characterization, Pharmacokinetic, and Pharmacodynamic PropertiesJournal of Drug Delivery, 2011
- Simulation of multiple ion channel block provides improved early prediction of compounds’ clinical torsadogenic riskCardiovascular Research, 2011
- Mechanism-based inhibition of human cytochrome P4503A4 by domperidoneXenobiotica, 2009
- Pharmacokinetics and Dose Proportionality of Domperidone in Healthy VolunteersThe Journal of Clinical Pharmacology, 1986